Home › Products › Oncology › Lengis 4mg Capsule
Lengis 4mg Capsule
Salt Composition: LENVATINIB
- Manufacturer: AEGIS PHARMACEUTICALS
- Pack Size: 10 CAPSULE(s) IN A BOTTLE
- Dosage Form: CAPSULE
- Strength: 4MG
- Prescription Required
- Storage: Lengis 4mg Capsule should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). Protected from light. Keep it in its original packaging until it is ready to be used. Keep reach out of the reach of children and pets. Should be disposed of properly.
₹844.00₹1383.00
Inclusive of all taxes
Product Introduction
Lengis 4mg Capsule contains lenvatinib, a tyrosine kinase inhibitor. It is indicated for progressive or advanced thyroid cancer when radioactive iodine therapy has not been effective. It is also used to treat previously untreated hepatocellular carcinoma in patients who are not candidates for surgical intervention. Anaplastic thyroid carcinoma, an advanced form of thyroid cancer, typically presents in patients aged 60 years and above. Clinical features include thyroid gland enlargement and hardness, along with hoarseness of the voice resulting from paralysis of the recurrent laryngeal nerve. Hepatocellular carcinoma develops in the setting of underlying liver disease, including cirrhosis or chronic hepatitis B infection. Patients with a known hypersensitivity to lenvatinib or any component of Lengis 4mg Capsule should not use this medication. Patients taking lenvatinib should inform their dentist or oral surgeon of this treatment, as the drug may affect wound healing and elevate bleeding risk.
Uses
Lengis 4mg Capsule is indicated to treat the following conditions: Certain types of advanced thyroid cancer Advanced Liver cancer Certain types of kidney cancer Endometrial cancer
How it works
Lengis 4mg Capsule blocks the enzyme receptor tyrosine kinases (RTKs). RTKs develop new blood vessels that supply oxygen and nutrients to the cells and help them grow. This medicine inhibits the receptors that facilitate the growth of blood vessels in tumor cells. RTKs are present in high concentrations in cancer cells, and administration of this medicine slows down the rate of cancer cellsâ growth and multiplication.
How to Use
Lengis 4mg Capsule is an oral medication that is usually taken once a day, at approximately the same time each day, with or without food. It should be taken as prescribed by a doctor or other healthcare provider. These capsules should be swallowed whole with a glass of water. They should not be crushed, chewed, or opened, as this can affect the way the medication is absorbed and decrease its effectiveness. You should not take a double dose to make up for the second dose.
Side Effects
Like all medications, Lengis 4mg Capsule Injection can cause side effects, although not everyone who takes it will experience them. Serious: Feeling numb or weak on 1 side of the body Severe headache Fever Confusion Difficulty speaking Vision changes Dizziness Chest pain or pressure Pain in arms, jaw, neck, back Breathing problems Severe stomach pain Blood clot formation Blood in stools or coughing blood Liver problems Pain or soreness in mouth, teeth or jaw Common: High or low BP Loss of appetite Nausea, vomiting, constipation, diarrhea or indigestion Tiredness Hoarse voice Leg swelling Rashes Pain in joints or muscles Hair loss Sleeplessness Protein in urine, frequent urination Low potassium, magnesium and calcium levels in the blood Dehydration Skin problems Gall bladder inflammation Increase in the values of cholesterol, thyroid-stimulating hormone, digestive enzymes Delayed wound healing
Expert Tips
If you are receiving close communication with your healthcare provider and report any concerns or side effects as soon as possible. Avoid getting pregnant and breastfeeding during treatment. Patients should use effective contraception while taking Lengis 4mg Capsule and for at least two weeks after stopping treatment. Patients should avoid eating grapefruits as they affect the absorption of this drug. Patients should use sunscreen and wear protective clothing while outdoors to reduce the risk of sunburn or skin damage. You should avoid strenuous activities or exercise until you know how this medication is affecting you. Maintain a healthy and balanced diet during treatment to support your overall health and well-being. By being informed and engaged in your treatment, you can help ensure the best possible outcomes and manage any potential risks or complications associated.
References
- Eisai Europe Limited, Electronic Medicines Compendium (EMC), [Revised on Mar 2021] [Accessed on 20th April 2023], https://www.medicines.org.uk/emc/files/pil.6840.pdf
- Suyama and Iwase, Lenvatinib: A promising molecular targeted agent for multiple cancers, Cancer Control, 2018, 25, 1-5, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056795/pdf/10/1177 1073274818789361.pdf
- Q.M. Anstee, D.E.J. Jones, Liver and Biliary Tract Disease, Davidsonâs Principles and Practice of Medicine, 22nd Edition, 2014, 921-988.
- M.W.J. Strachan, J. Newell-Price, Endocrine disease, Davidsonâs Principles & Practice of Medicine, 22nd Edition, 2014, 733-796.
- Eisai Inc U.S Food and Safety Drug Administration (FDA) [Last revised Aug 2018], [Accessed on 20th April 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206947s007lbl.pdf
Safety Advice
Pregnancy: unsafe Lengis 4mg Capsule is unsafe during pregnancy as it can cause fetal harm. It is s recommended to avoid this medication during pregnancy.
Lungs: Consult your doctor Lengis 4mg Capsule can cause side effects that affect the lungs, such as cough, shortness of breath, and difficulty breathing. If a person experiences any of these symptoms while taking it, they should notify their healthcare provider right away.
Breastfeeding: unsafe Breastfeeding is not recommended while taking Lengis 4mg Capsule, as it can potentially harm the nursing infant.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.